Vaxcyte Inc.
Organization details
- Legal name
- Vaxcyte Inc.
- Former names
- SutroVax, Inc.
- Ownership
- Public
- Status
- Active
- Sector (GICS)
- Health Care
- SIC code
- 2836 — Biological Products, (No Diagnostic Substances)
- Jurisdiction of incorporation
- Delaware
- Headquarters city
- SAN Carlos
- Headquarters state / province
- California
- Headquarters country
- United States
- Fiscal year end
- December
- Ticker symbol
- PCVX
- Primary stock exchange
- Nasdaq
Identifiers
- SEC CIK
- 0001649094
- EIN
- 46-4233385
Board of directors
-
Anne S. Drapeau · DirectorSince 2023
-
Carlos Paya V · DirectorSince 2023
-
Grant Pickering · Director · CHIEF EXECUTIVE OFFICERSince 2023
-
Halley E. Gilbert · DirectorSince 2023
-
Heath Lukatch · DirectorSince 2023
-
Jacks Lee · DirectorSince 2023
-
John Furey · DirectorSince 2024
-
John Markels · DirectorSince 2026
-
Michael E. Kamarck · DirectorSince 2023
-
Moncef Slaoui · DirectorSince 2026
-
Olivier Brandicourt · DirectorSince 2025
-
Peter Hirth · DirectorSince 2023
-
Teri Loxam · DirectorSince 2023
Chief executives
Director election results
Annual meeting of June 6, 2024. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
83.7%
-
97.6%
-
97.8%
Board connections
8 of this board's directors also sit on 10 other boards. 10 are in the same sector.
-
Arcturus Therapeutics Holdings Inc. Same sectorvia John Markels and Moncef Slaoui
-
Aligos Therapeutics Inc. Same sectorvia Peter Hirth
-
Alnylam Pharmaceuticals Inc. Same sectorvia Olivier Brandicourt
-
Arcutis Biotherapeutics Inc. Same sectorvia Halley E. Gilbert
-
BeOne Medicines Ltd. Same sectorvia Olivier Brandicourt
-
Collegium Pharmaceutical Inc. Same sectorvia Carlos Paya V
-
CytomX Therapeutics Inc. Same sectorvia Halley E. Gilbert
-
LeonaBio Inc. Same sectorvia Grant Pickering
-
Passage Bio Inc. Same sectorvia Michael E. Kamarck
-
Standard BioTools Inc. Same sectorvia Carlos Paya V
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $0
- 0 purchases by 0 insiders
- Sold, last 12 months
- $12,742,274
- 58 sales by 5 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Nov 2, 2026 | Cowan Elvia Officer (SVP, Finance & CAO) | Option exercise | +3,000 | $25.92 | $77,760 |
| Nov 2, 2026 | Wassil Jim Officer (EVP, Chief Scientific Ofc, COO) | Option exercise | +2,250 | $5.35 | $12,038 |
| Nov 2, 2026 | Cowan Elvia Officer (SVP, Finance & CAO) | Open-market sale | −2,414 | $60.77 | $146,687 |
| Nov 2, 2026 | Wassil Jim Officer (EVP, Chief Scientific Ofc, COO) | Open-market sale | −1,907 | $60.78 | $115,906 |
| Nov 2, 2026 | Cowan Elvia Officer (SVP, Finance & CAO) | Open-market sale | −586 | $61.55 | $36,067 |
| Nov 2, 2026 | Wassil Jim Officer (EVP, Chief Scientific Ofc, COO) | Open-market sale | −343 | $61.57 | $21,119 |
| Oct 5, 2026 | Cowan Elvia Officer (SVP, Finance & CAO) | Option exercise | +19,000 | $25.92 | $492,480 |
| Oct 5, 2026 | Wassil Jim Officer (EVP, Chief Scientific Ofc, COO) | Option exercise | +18,000 | $5.35 | $96,300 |
| Oct 5, 2026 | Cowan Elvia Officer (SVP, Finance & CAO) | Open-market sale | −19,000 | $86.74 | $1,648,060 |
| Oct 5, 2026 | Wassil Jim Officer (EVP, Chief Scientific Ofc, COO) | Open-market sale | −18,000 | $86.74 | $1,561,320 |
| Oct 1, 2026 | Wassil Jim Officer (EVP, Chief Scientific Ofc, COO) | Option exercise | +2,250 | $5.35 | $12,038 |
| Oct 1, 2026 | Wassil Jim Officer (EVP, Chief Scientific Ofc, COO) | Open-market sale | −2,155 | $56.65 | $122,089 |
| Oct 1, 2026 | Wassil Jim Officer (EVP, Chief Scientific Ofc, COO) | Open-market sale | −95 | $57.09 | $5,424 |
| Sep 9, 2026 | Wassil Jim Officer (EVP, Chief Scientific Ofc, COO) | Open-market sale | −1,334 | $59.52 | $79,400 |
| Sep 8, 2026 | Cowan Elvia Officer (SVP, Finance & CAO) | Shares withheld for tax | −1,327 | $60.36 | $80,098 |
Peers
Compare boardsOrganizations in the same sector, closest in location and size first.
Questions about Vaxcyte Inc.
Who is the CEO of Vaxcyte Inc.?
Grant Pickering is Vaxcyte Inc.'s Chief Executive Officer.
How many directors are on Vaxcyte Inc.'s board?
Vaxcyte Inc.'s board has 13 directors: Anne S. Drapeau, Carlos Paya V, Grant Pickering, Halley E. Gilbert, Heath Lukatch, Jacks Lee, John Furey, John Markels, Michael E. Kamarck, Moncef Slaoui and 3 others.
Are Vaxcyte Inc. insiders buying or selling shares?
Over the last 12 months, Vaxcyte Inc. insiders made no open-market purchases and sold $12.7 million of shares in 58 sales on the open market, as reported to the SEC on Forms 4 and 5.
Embed this board on your site
Paste this where the board should appear. It always shows the current directors and links back here.
<div data-bod-board="vaxcyte-inc"></div>
<script src="https://boardofdirectors.review/embed.js" async></script>Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.